CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018		Dec. 31, 2017		Dec. 31, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:
Net earnings	$ 43,003		$ 37,976		$ 60,430
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	24,104		23,916		20,457
Amortization of deferred financing cost	333		343		346
Increase to allowance for doubtful accounts	330		972		210
Increase to inventory reserves	3,978		3,300		5,371
Amortization of deferred gain on sale of buildings	(218)		(1,048)		(1,048)
Gain on sale of property, plant and equipment	(3,997)		(15)		(7)
Equity (income) loss from joint ventures	768	[1]	602	[1],[2]	(2,029)	[2]
Employee Stock Ownership Plan allocation	2,557		2,159		2,021
Stock-based compensation	7,998		7,638		6,127
Excess tax benefits related to exercise of employee stock grants	0		0		(849)
(Increase) decrease in deferred income taxes	(10,046)		19,059		(691)
Increase (decrease) in tax valuation allowance	22		(128)		65
Loss on discontinued operations, net of tax	13,851		5,654		1,982
Change in assets and liabilities:
Increase in accounts receivable	(13,699)		(5,100)		(8,826)
Increase in inventories	(30,199)		(13,901)		(20,155)
(Increase) decrease in prepaid expenses and other current assets	4,926		(4,869)		3,475
Increase (decrease) in accounts payable	16,894		(7,186)		7,345
Increase (decrease) in sundry payables and accrued expenses	8,407		(6,015)		20,990
Net change in other assets and liabilities	1,246		1,260		2,591
Net cash provided by operating activities	70,258		64,617		97,805
CASH FLOWS FROM INVESTING ACTIVITIES:
Acquisitions of and investments in businesses	(9,852)		(6,808)		(67,289)
Capital expenditures	(20,141)		(24,442)		(20,921)
Other investing activities	107		22		192
Net cash used in investing activities	(29,886)		(31,228)		(88,018)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net borrowings (repayments) under line-of-credit agreements	(13,311)		2,188		7,384
Net borrowings of other debt and capital lease obligations	1,115		4,065		89
Purchase of treasury stock	(14,886)		(24,376)		(377)
Increase (decrease) in overdraft balances	275		(534)		(254)
Payments of debt issuance costs	(460)		0		0
Excess tax benefits related to the exercise of employee stock grants	0		0		849
Dividends paid	(18,854)		(17,287)		(15,447)
Net cash used in financing activities	(46,121)		(35,944)		(7,756)
Effect of exchange rate changes on cash	(436)		82		(1,035)
Net increase (decrease) in cash and cash equivalents	(6,185)		(2,473)		996
CASH AND CASH EQUIVALENTS at beginning of year	17,323		19,796		18,800
CASH AND CASH EQUIVALENTS at end of year	11,138		17,323		19,796
Cash paid during the year for:
Interest	3,738		1,944		1,207
Income taxes	15,353		34,543		32,505
Noncash investing activity:
Accrual for final contribution of acquired investment	0		5,740		0
Receivable related to net proceeds from sale of Grapevine, Texas facility	$ 4,801		$ 0		$ 0

[1] Year ended December 31, 2018 and 2017 includes a noncash impairment charge of approximately $1.7 million and $1.8 million, respectively, related to our minority interest investment in Orange Electronic Co., Ltd. (See Note 10 for additional information).

[2] Net periodic benefit credit (cost) has been reclassified from selling, general and administrative expenses to other non-operating income (expense), net on our consolidated statement of operations upon adoption of ASU 2017-07, Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost, see Note 1, "Summary of Significant Accounting Policies" for additional information.